Search research articles
Contact Us
Filters
Showing results (251-260 of 321) with videos related to
Page
of 33
Sort By:
ACS Nano
|
October 20, 2022
Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer
Fei Wu, Pei-Ming Chen, Thomas C Gardinier, et al.
Cell Host & Microbe
|
November 17, 2007
Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC
Stephen B Willingham, Daniel T Bergstralh, William O'Connor, et al.
Journal of Medicinal Chemistry
|
December 14, 2004
Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates
Aranapakam M Venkatesan, Yansong Gu, Osvaldo Dos Santos, et al.
Urology
|
December 29, 2011
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer
Hari Trivedi, Baris Turkbey, Ardeshir R Rastinehad, et al.
Digestive Diseases and Sciences
|
May 2, 2021
Gastrointestinal Computed Tomography Findings in Chronic Granulomatous Disease with Subgroup Clinicopathologic Analysis
Sumona Bhattacharya, Yilun Koethe, Alexander Ling, et al.
BMC Cancer
|
October 10, 2020
Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial
Lucas C Mendez, Andrew J Arifin, Glenn S Bauman, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 18, 1999
Prodrugs of CL316243: a selective beta3-adrenergic receptor agonist for treating obesity and diabetes
F W Sum, A Gilbert, A M Venkatesan, et al.
The Lancet. Oncology
|
September 21, 2007
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial
Li-Yan Khor, Kyounghwa Bae, Alan Pollack, et al.
Infection and Immunity
|
March 6, 2014
Development of an Aotus nancymaae model for Shigella Vaccine immunogenicity and efficacy studies
Michael Gregory, Robert W Kaminski, Luis A Lugo-Roman, et al.
Journal of Clinical Immunology
|
August 14, 2017
Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome
Manish Arora, Preet Bagi, Anna Strongin, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 321) with videos related to
Sort By:
Page
of 33
ACS Nano
|
October 20, 2022
Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer
Fei Wu, Pei-Ming Chen, Thomas C Gardinier, et al.
Cell Host & Microbe
|
November 17, 2007
Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC
Stephen B Willingham, Daniel T Bergstralh, William O'Connor, et al.
Journal of Medicinal Chemistry
|
December 14, 2004
Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates
Aranapakam M Venkatesan, Yansong Gu, Osvaldo Dos Santos, et al.
Urology
|
December 29, 2011
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer
Hari Trivedi, Baris Turkbey, Ardeshir R Rastinehad, et al.
Digestive Diseases and Sciences
|
May 2, 2021
Gastrointestinal Computed Tomography Findings in Chronic Granulomatous Disease with Subgroup Clinicopathologic Analysis
Sumona Bhattacharya, Yilun Koethe, Alexander Ling, et al.
BMC Cancer
|
October 10, 2020
Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial
Lucas C Mendez, Andrew J Arifin, Glenn S Bauman, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 18, 1999
Prodrugs of CL316243: a selective beta3-adrenergic receptor agonist for treating obesity and diabetes
F W Sum, A Gilbert, A M Venkatesan, et al.
The Lancet. Oncology
|
September 21, 2007
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial
Li-Yan Khor, Kyounghwa Bae, Alan Pollack, et al.
Infection and Immunity
|
March 6, 2014
Development of an Aotus nancymaae model for Shigella Vaccine immunogenicity and efficacy studies
Michael Gregory, Robert W Kaminski, Luis A Lugo-Roman, et al.
Journal of Clinical Immunology
|
August 14, 2017
Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome
Manish Arora, Preet Bagi, Anna Strongin, et al.
Page
of 33